China · Delayed Price · Currency is CNY Shanghai Hile Bio-Technology Company Description
Shanghai Hile Bio-Technology Co., Ltd. researches, develops, produces, and sells veterinary biological products for livestock and poultry in China.
The company offers swine fever live vaccines; trivalent inactivated vaccines for piglets; and inactivated vaccine for streptococcus suis.
It also provides inactivated avian infectious rhinitis vaccines; newcastle disease and avian influenza combined inactivated vaccines; newcastle disease, infectious bronchitis, egg drop syndrome, and avian influenza quadruple inactivated vaccines; avian influenza inactivated vaccines; newcastle disease, infectious bronchitis, and avian influenza triple inactivated vaccines; avian infectious bronchitis live vaccines; avian newcastle disease, and avian infectious bronchitis combined live vaccines.
The company was founded in 1981 and is based in Shanghai, China.
| Country | China |
| Founded | 1981 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 366 |
| CEO | Benyi Han |
Contact Details
Address: No. 138 Huaihai Middle Road Shanghai, 200001 China | |
| Phone | 86 21 6089 0888 |
| Website | hile-bio.com |
Stock Details
| Ticker Symbol | 603718 |
| Exchange | Shanghai Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE1000022T4 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Benyi Han | GM and Director |
| Wang Xingchun | Financial Officer |
| Xiao Chen | Deputy GM and Director |
| Dongchan Pu | Deputy GM and Secretary of the Board |
| Xiang Xiaoqiang | Deputy General Manager |